Filius to depart Galapagos

Bart Filius will step down as president, COO and CFO at Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) on June 30. Filius joined the company in 2014 as CFO, became COO in 2017 and was named president in 2021. A search for his successor is ongoing.

Louise Modis joined Amphista Therapeutics Ltd., a targeted protein degradation company, as CSO, succeeding Ian Churcher, who becomes CTO. Modis was CSO at Mogrify Ltd., and previously held roles at GSK plc (LSE:GSK; NYSE:GSK) and Boehringer Ingelheim GmbH...